NCT04529707 |
Sleep Intervention in Young Boys With Duchenne Muscular Dystrophy (DMD) |
Behavioural therapy |
Transdiagnostic Behavioral Sleep Intervention |
DMD |
≥18 years |
University of Pittsburgh, United States |
United States |
NCT04353167 |
Effect of Foot Structure and Foot and Body Posture on Gait and Balance in Duchenne Muscular Dystrophy |
None |
|
Ambulant |
5 - 13 years |
Hacettepe University, Turkey |
Turkey |
NCT04287582 |
The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy |
Device |
Electromyographic device |
DMD and controls |
5 - 12 years |
Hacettepe University, Turkey |
Turkey |
NCT03947112 |
Physical Activity Level of Norwegian Boys With Duchenne Muscular Dystrophy |
None |
|
|
6 - 18 years |
Haukeland University Hospital, Norway |
Norway |
NCT04173234 |
Aerobic Exercise in Duchenne Muscular Dystrophy |
Aerobic Training |
Home exercise program |
Ambulant |
5 - 12 years |
Hacettepe University, Turkey |
Turkey |
NCT04120168 |
Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease (VICTORIA) |
None |
|
|
3 months - 18 years |
Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition, Turkey |
Turkey |
NCT04012671 |
A Registered Cohort Study on Duchenne Muscular Dystrophy |
None |
|
Chinese DMD patients |
>2 years |
Hospital of Fujian Medical University, China |
China |
NCT03760029 |
A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy |
None |
|
All Chinese DMD patients |
- |
Pfizer |
China |
NCT03611244 |
Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device |
Device |
Portable seat |
Non-ambulant |
7 - 15 years |
Seoul National University Hospital, South Korea |
Korea Republic Of |
NCT03531788 |
Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD |
Device |
Armon Ayura (Kinova)/ JAECO Wrex |
Non-ambulant |
>14 years |
University of Pittsburgh, United States |
United States |
NCT03513367 |
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM. (ValPedsQLDMD) |
None |
|
|
7 - 18 years |
University Hospital, Toulouse, France |
France |
NCT03507530 |
Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy |
None |
|
Ambulant |
6 - 15 years |
Hacettepe University, Turkey |
Turkey |
NCT03443115 |
Duchenne Muscular Dystrophy Heart Study (DMD-HS) |
None |
Retrospective study |
All patients are eligible |
- |
Hôpital Cochin, Paris, France |
France |
NCT03127241 |
User-centred Assistive System for Arm Functions in Neuromuscular Subjects (USEFUL) |
Device |
Armon Ayura / JAECO Wrex |
DMD, BMD or other muscular dystrophy;
Non-ambulant |
<15 years |
Politecnico di Milano, Italy |
Italy |
NCT02994030 |
Biomarker for Duchenne Disease (BIODUCHENNE) |
None |
|
|
2 months - 6 years |
Centogene AG Rostock |
Egypt, Germany, India, Lebanon, Lithuania, Sri Lanka, United Arab Emirates |
NCT02834650 |
Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD |
None |
|
DMD and controls |
7 - 21 years |
University of California, Los Angeles, United States |
United States |
NCT02789059 |
Muscle Oxygenation in Effort in Neuromuscular Diseases (OXYNEMU) |
None |
|
DMD, BMD, or other muscular dystrophy or myopathy, and controls |
18 - 70 years |
University Hospital, Lille, France |
France |
NCT02780492 |
Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study |
None |
|
|
5 - 18 years |
University College, London, United Kingdom |
France, Netherlands, United Kingdom |
NCT02472990 |
Biomechanical and Morphological Changes in Dystrophic Muscle (MARCHE-DMD) |
None |
|
Ambulant |
5 - 17 years |
University Hospital, Brest, France |
France |
NCT02470962 |
Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy |
None |
|
DMD/BMD |
8 - 18 years |
University Children's Hospital, Zurich. Switzerland |
Switzerland |
NCT02109692 |
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies (biodystromirs) |
None |
|
DMD or other muscular dystrophy |
18 months - 80 years |
University Hospital, Montpellier, France |
France |
NCT02069756 |
The Duchenne Registry (Previously DuchenneConnect) |
None |
|
DMD/BMD;
All ages |
- |
The Duchenne Registry, PPMD, United States |
United States |
NCT01823783 |
Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy |
None |
|
|
2 - 15 years |
University Hospital, Montpellier, France |
France |
NCT01506518 |
Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy |
None |
|
Ambulant |
5 - 13 years |
University of North Carolina, Chapel Hill, United States |
United States |
NCT00390104 |
Molecular Analysis of Patients With Neuromuscular Disease |
None |
|
DMD, BMD or other neuromuscular disease |
<100 years |
Boston Children’s Hospital, United States |
United States |
NCT03882827 |
Natural History of Duchenne Muscular Dystrophy |
None |
|
Ambulant |
5 - 9 years |
Genethon |
France, United Kingdom |